[ Cue raises $15.5M in Series B ]

Cue has raised $15.5 million in Series B funding.

Founded in 2010, Cue develops a consumer health device that allows users to track testosterone, influenza, fertility and vitamin D levels via smartphone.

For the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user’s smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

Funding  Series B
Founded  2010
Country  USA
City  San Diego, California
Founder / CEO  Mr. Ayub Khattak
Deal Size  $15.5M
Investors  Sherpa Capital
 Rohan Oza
Previous Investors  Dentsu Ventures
 Highway1
 Sherpa Capital
 Jim Messina
 Leonardo DiCaprio
 Marc Benioff
 Immortalana